Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells

Free Radical Biology and Medicine

Volumn 49, Issue 4, 2010, Pages 559-566

  Erkekoǧlu, Pinar ^a,b   Rachidi, Walid ^a   De Rosa, Viviana ^a   Giray, Belma ^b   Favier, Alain ^a   Hincal, Filiz ^b  

^a CEA GRENOBLE   (France)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Comet assay; Di(2 ethylhexyl)phthalate; DNA damage; Glutathione peroxidase; Mono(2 ethylhexyl)phthalate; Oxidative stress; Selenium

Indexed keywords

GLUTATHIONE PEROXIDASE 1; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; SELENOMETHIONINE; SODIUM SELENITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL STRAIN LNCAP; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG MECHANISM; GENOTOXICITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTIOXIDANTS; CELL SURVIVAL; DIETHYLHEXYL PHTHALATE; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; SELENOMETHIONINE; SODIUM SELENITE; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 77954511322     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.04.038     Document Type: Article

References (58)

1. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
2. Turner T.T., Lysiak J.J. Oxidative stress: a common factor in testicular dysfunction. J. Androl. 2008, 29:488-498.
3. Soory M. Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. Infect. Disord. Drug Targets 2009, 9:400-414.
4. Fischer J.L., Lancia J.K., Mathur A., Smith M.L. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res. 2006, 26:899-904.
5. Ganther D.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoixn reductase. Carcinogenesis 1999, 20:1657-1666.
6. Duffield-Lillico A.J., Reid M.E., Turnbull B.W., Combs G.F., Slate E.H., Fischbach L.A., Marshall J.R., Clark L.C. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev. 2002, 11:630-639.
7. Oberley T.D., Zhong W., Szweda L.I., Oberley L.W. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 2000, 44:144-155.
8. Zhong W., Oberley T.D. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res. 2001, 61:7071-7078.
9. Chung L.W., Li W., Gleave M.E., Hsieh J.T., Wu H.C., Sikes R.A., Zhau H.E., Bandyk M.G., Logothetis C.J., Rubin J.S. Human prostate cancer model: roles of growth factors and extracellular matrices. J. Cell Biochem. Suppl. 1992, 16H:99-105.
10. Rusyn I., Peters J.M., Cunningham M.L. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit. Rev. Toxicol. 2006, 36:459-479.
11. Lyche J.L., Gutleb A.C., Bergman A., Eriksen G.S., Murk A.J., Ropstad E., Saunders M., Skaare J.U. Reproductive and developmental toxicity of phthalates. J Toxicol. Environ. Health B Crit. Rev. 2009, 12:225-249.
12. Noriega N.C., Howdeshell K.L., Furr J., Lambright C.R., Wilson V.S., Gray L.E. Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats. Toxicol. Sci. 2009, 111:163-178.
13. Zhang Y.H., Lin L., Liu Z.W., Jiang X.Z., Chen B.H. Disruption effects of monophthalate exposures on inter-Sertoli tight junction in a two-compartment culture model. Environ. Toxicol. 2008, 23:302-308.
14. Ge R.S., Chen G.R., Tanrikut C., Hardy M.P. Phthalate ester toxicity in Leydig cells: developmental timing and dosage considerations. Reprod. Toxicol. 2007, 23:366-373.
15. Gazouli M., Yao Z.X., Boujrad N., Corton J.C., Culty M., Papadopoulos V. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology 2002, 143:2571-2583.
16. O'Brien M.L., Spear B.T., Glauert H.P. Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit. Rev. Toxicol. 2005, 35:61-88.
17. Anderson D., Yu T.W., Hincal F. Effect of some phthalate esters in human cells in the comet assay. Teratog. Carcinog. Mutagen. 1999, 19:275-280.
18. Kleinsasser N.H., Harréus U.A., Kastenbauer E.R., Wallner B.C., Sassen A.W., Staudenmaier R., Rettenmeier A.W. Mono(2-ethylhexyl)phthalate exhibits genotoxic effects in human lymphocytes and mucosal cells of the upper aerodigestive tract in the comet assay. Toxicol. Lett. 2004, 148:83-90.
19. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991, 3:207-212.
20. Flohé L., Günzler W.A. Assays of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
21. Arner E.S., Zhong L., Holmgren A. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol. 1999, 300:226-239.
22. Goldberg D.M., Spooner R.J. Glutathione reductase. Methods of enzymatic analysis 1983, 258-265. Verlag Chemie, Basal. H.U. Bergmeyer, J. Bergmeyer, M. Grabl (Eds.).
23. Habig W.H., Pabst M.J., Jakoby W.B. Glutathion S-transferases, the first enzymatic step in mercapturic acid formation. Biol. Chem. 1974, 249:7130-7139.
24. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 1981, 77:373-382.
25. Krieg R.C., Dong Y., Schwamborn K., Knuechel R. Protein quantification and its tolerance for different interfering reagents using the BCA-method with regard to 2D SDS PAGE. J. Biochem. Biophys. Methods 2005, 65:13-19.
26. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
27. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
28. Rusyn I., Kadiiska M.B., Dikalova A., Kono H., Yin M., Tsuchiya K., Mason R.P., Peters J.M., Gonzalez F.J., Segal B.H., Holland S.M., Thurman R.G. Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells. Mol. Pharmacol. 2001, 59:744-750.
29. Kasahara E., Sato E.F., Miyoshi M., Konaka R., Hiramoto K., Sasaki J., Tokuda M., Nakano Y., Inoue M. Role of oxidative stress in germ cell apoptosis induced by di(2-ethylhexyl)phthalate. Biochem. J. 2002, 365:849-856.
30. Onorato T.M., Brown P.W., Morris P.L. Mono-(2-ethylhexyl) phthalate increases spermatocyte mitochondrial peroxiredoxin 3 and cyclooxygenase 2. J. Androl. 2008, 29:293-303.
31. Mansur D.B., Hao H., Gladyshev V.N., Korotkov K.V., Hu Y., Moustafa M.E., El-Saadani M.A., Carlson B.A., Hatfield D.L., Diamond A.M. Multiple levels of regulation of selenoprotein biosynthesis revealed from the analysis of human glioma cell lines. Biochem. Pharmacol. 2000, 60:489-497.
32. Bhamre S., Whitin J.C., Cohen H.J. Selenomethionine does not affect PSA secretion independent of its effect on LNCaP cell growth. Prostate 2003, 54:315-321.
33. Zhuo P., Goldberg M., Herman L., Lee B.S., Wang H., Brown R.L., Foster C.B., Peters U., Diamond A.M. Cancer Res. Molecular consequences of genetic variations in the glutathione peroxidase 1 selenoenzyme. Cancer Res. 2009, 69:8183-8190.
34. Hu Y.J., Diamond A.M. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003, 63:3347-3351.
35. Baliga M.S., Wang H., Zhuo P., Schwartz J.L., Diamond A.M. Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage. Biol. Trace Elem. Res. 2007, 115:227-242.
36. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30:445-600.
37. Gromer S., Urig S., Becker K. The thioredoxin system-from science to clinic. Med. Res. Rev. 2004, 24:40-89.
38. Arnér E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 2000, 267:6102-6109.
39. Xia L., Nordman T., Olsson J.M., Damdimopoulos A., Björkhem-Bergman L., Nalvarte I., Eriksson L.C., Arnér E.S., Spyrou G., Björnstedt M. The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress. Biol. Chem. 2003, 278:2141-2146.
40. Gandin V., Nyström C., Rundlöf A.K., Jönsson-Videsäter K., Schönlau F., Hörkkö J., Björnstedt M., Fernandes A.P. Effects of the antioxidant Pycnogenol on cellular redox systems in U1285 human lung carcinoma cells. FEBS J. 2009, 276:532-540.
41. Hauser R., Meeker J.D., Singh N.P., Silva M.J., Ryan L., Duty S., Calafat A.M. DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum. Reprod. 2007, 22:688-695.
42. Emonet-Piccardi N., Richard M.J., Ravanat J.L., Signorini N., Cadet J., Béani J.C. Protective effects of antioxidants against UVA-induced DNA damage in human skin fibroblasts in culture. Free Radic. Res. 1998, 29:307-313.
43. Rafferty T.S., Green M.H., Lowe J.E., Arlett C., Hunter J.A., Beckett G.J., McKenzie R.C. Effects of selenium compounds on induction of DNA damage by broadband ultraviolet radiation in human keratinocytes. Br. J. Dermatol. 2003, 148:1001-1009.
44. Waters D.J., Shen S., Cooley D.M., Bostwick D.G., Qian J., Combs G.F., Glickman L.T., Oteham C., Schlittler D., Morris J.S. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J. Natl. Cancer Inst. 2003, 95:237-241.
45. Waters D.J., Shen S., Glickman L.T., Cooley D.M., Bostwick D.G., Qian J., Combs G.F., Morris J.S. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 2005, 26:1256-1262.
46. Letavayová L., Vlcková V., Brozmanová J. Selenium: from cancer prevention to DNA damage. Toxicology 2006, 227:1-14.
47. Seko Y., Saito Y., Kitahara J., Imura N. Active oxygen generation by the reaction of selenite with reduced glutathione in vitro. Selenium in biology and medicine 1989, 70-73. Springer-Verlag, Berlin. A. Wendel (Ed.).
48. Stewart M.S., Spallholz J.E., Neldner K.H., Pence B.C. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic. Biol. Med. 1999, 26:42-48.
49. Hartwig A., Blessing H., Schwerdtle T., Walter I. Modulation of DNA repair processes by arsenic and selenium compounds. Toxicology 2003, 193:161-169.
50. Li G.X., Hu H., Jiang C., Schuster T., Lü J. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells. Int. J. Cancer 2007, 120:2034-2043.
51. Seo Y.R., Sweeney C., Smith M.L. Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene 2002, 21:3663-3669.
52. Collins A.R., Harrington V., Drew J., Melvin R. Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis 2003, 24:511-515.
53. Laffon B., Valdiglesias V., Pásaro E., Méndez J. The organic selenium compound selenomethionine modulates bleomycin-induced DNA damage and repair in human leukocytes. Biol. Trace Elem. Res. 2010, 133:12-19.
54. Valdiglesias V., Pásaro E., Méndez J., Laffon B. In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: a review. Arch. Toxicol. 2010, 84:337-351.
55. Gladyshev V.N., Hatfield D.L. Selenocysteine-containing proteins in mammals. J. Biomed. Sci. 1999, 6:151-160.
56. Calvo A., Xiao N., Kang J., Best C.J., Leiva I., Emmert-Buck M.R., Jorcyk C., Green J.E. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res. 2002, 62:5325-5335.
57. Kumaraswamy E., Malykh A., Korotkov K.V., Kozyavkin S., Hu Y., Kwon S.Y., Moustafa M.E., Carlson B.A., Berry M.J., Lee B.J., Hatfield D.L., Diamond A.M., Gladyshev V.N. Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J. Biol. Chem. 2000, 275:35540-35547.
58. Rhee S.G., Chae H.Z., Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38:1543-1552.